Polycystic Ovary by Sonography
Find information on thousands of medical conditions and prescription drugs.

Hyperandrogenism

Polycystic ovary syndrome (PCOS, also known clinically as Stein-Leventhal syndrome), is an endocrine disorder that affects 5–10% of women. It occurs amongst all races and nationalities, is the most common hormonal disorder among women of reproductive age, and is a leading cause of infertility. The symptoms and severity of the syndrome vary greatly between women. While the causes are unknown, insulin resistance (often secondary to obesity) is heavily correlated with PCOS. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Nomenclature

Other names for this disorder include:

  • Polycystic ovary disease (although this is not correct, as PCOS is characterised as a syndrome rather than a disease)
  • Functional ovarian hyperandrogenism
  • Hyperandrogenic chronic anovulation
  • Ovarian dysmetabolic syndrome

Definition

There are two definitions that are commonly used:

  1. In 1990 a consensus workshop sponsored by the NIH/NICHD suggested that a patient has PCOS if she has (1) signs of androgen excess (clinical or biochemical), (2) oligoovulation, and (3) other entities are excluded that would cause polycystic ovaries.
  2. In 2003 a consensus workshop sponsored by ESHRE/ASRM in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: (1) oligoovulation and/or anovulation, (2) excess androgen activity, (3) polycystic ovaries (by gynecologic ultrasonography), and other causes of PCOS are excluded.

The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, while in the NIH/NICHD definiton androgen excess is a prerequisite. Critics maintain that findings obtained from the study of patients with androgen excess cannot be necessarily extrapolated to patients without androgen excess.

Signs and symptoms

Common symptoms of PCOS include:

  • Oligomenorrhea, amenorrhea - irregular/few, or absent, menstrual periods; cycles that do occur may comprise heavy bleeding (check with a gynaecologist, since heavy bleeding is also an early warning sign of endometrial cancer, for which women with PCOS are at higher risk)
  • Infertility, generally resulting from chronic anovulation (lack of ovulation)
  • Elevated serum (blood) levels of androgens (male hormones), specifically testosterone, androstenedione, and dehydroepiandrosterone sulfate (DHEAS), causing hirsutism and occasionally masculinization
  • Central obesity - "apple-shaped" obesity centered around the lower half of the torso
  • Androgenic alopecia (male-pattern baldness)
  • Acne / oily skin / seborrhea
  • Acanthosis nigricans (dark patches of skin, tan to dark brown/black)
  • Acrochordons (skin tags) - tiny flaps of skin
  • Prolonged periods of PMS-like symptoms (bloating, mood swings, pelvic pain, backaches)
  • Sleep apnea

Signs are:

  • Multiple cysts on the ovaries. Sonographycally they may present as a "string of pearls".
  • Enlarged ovaries, generally 1.5 to 3 times larger than normal, resulting from multiple cysts
  • Thickened, smooth, pearl-white outer surface of ovary
  • Chronic pelvic pain, possibly due to pelvic crowding from enlarged ovaries; however, the actual cause is not yet known
  • The ratio of LH (Luteinizing hormone) to FSH (Follicle stimulating hormone) is 2:1 or more, particularly in the early phase of the menstrual cycle.
  • Increased levels of testosterone.
  • Decreased levels of sex hormone binding globulin.
  • Hyperinsulinemia.

Read more at Wikipedia.org


[List your site here Free!]


Polycystic Ovary Syndrome and a Low Glycemic Index Diet
From Canadian Journal of Dietetic Practice and Research, 7/1/05 by Allen, Cheryl

INTRODUCTION

Polycystic ovary syndrome (PCOS), a combination of metabolic, endocrine and reproductive irregularities, may be the most common endocrine disorder and cause of infertility seen in women (Marshall, 2001). A true estimate of prevalence is not available, due to differences in diagnostic criteria; however, rates could be as high as 10% in the North American female population (Hoyt et al., 2004).

PRESENTATION

Symptoms of PCOS commonly include amenorrhea or oligomenorrhea, anovulation or irregular ovulation, infertility, presence of ovarian cysts, enlarged ovaries, hyperandrogenism, weight gain, male pattern fat distribution and hair loss, excess facial and body hair, skin tags, and acne (Marshall, 2001). Women with PCOS experience abnormal androgen production, the cause of which is unknown. An outcome of this hormone imbalance is hyperinsulinemia and consequent insulin resistance (Balen, 2004). Thus, women with PCOS are often diagnosed with type II diabetes. Fifty percent of women with PCOS are obese (Marshall, 2001) and many have hypertension and dyslipidemia.

MANAGEMENT

There is no specific treatment for PCOS. Instead, physicians who practice traditional western medicine try to alleviate symptoms through various drugs that target the different attributes of the disease. Drugs include oral contraceptives, insulin-sensitizing agents and anti-androgen drugs (Marshall, 2001). The potential ineffectiveness, costs and side effects of these drugs has spurred research into alternative treatment options, including diet and lifestyle interventions.

Role of diet

Due to the relationship between hyperinsulinemia and hyperandrogenism, improved insulin sensitivity may decrease androgen production, and thereby minimize many of the symptoms associated with PCOS (Hoyt et al., 2004). Diet and lifestyle changes are helpful in managing insulin sensitivity. Nutrition research has focused on the low glycemic index (GI) diet and reducing body mass. Both interventions have been shown to improve insulin sensitivity, thereby improving reproductive hormone imbalances (Hamilton & Fairly, 2000: Clark et al, 1995). Foods with a low GI are slowly digested and produce a prolonged postprandial insulin release (Augustine et al., 2002). Choosing foods that supply glucose to the cells at a steady rate results in moderate insulin demands and may help improve insulin resistance (Bell & Sears, 2003).

Studies have shown that a 5-10% reduction in weight can potentially improve serum androgen levels and fertility in obese women with PCOS (Moran & Norman, 2004), so weight reduction should be highly recommended for these women (Moran & Norman, 2004). Simple carbohydrates and breads made from refined flour products may aggravate insulin resistance and promote weight gain, thereby compounding symptoms associated with PCOS (Scalzo & McKittrick, 2000). Conversely, a low GI diet is associated with weight loss in women with PCOS because it emphasizes high fibre vegetables, legumes and fruit, lean protein, whole grains and heart-healthy fats, leading to increased satiety and less overeating (Scalzo & McKittrick, 2000). A low GI diet could be beneficial in the treatment of PCOS by improving insulin sensitivity and promoting weight loss. The low GI diet is easy to follow, includes foods from all four food groups and therefore may be used as a safe and feasible lifestyle approach to managing PCOS (GilbertsonetaL, 2003).

Nutrient supplements have possible benefits for the treatment of insulin resistance associated with PCOS. These include: omega-3 fatty acids, which are found in fish oil and increase glycogen storage (Clarke, 2000), chromium, a mineral involved in insulin utilization pathways in the body (Schmidt-Finney & GonzalezCampoy, 1997) and d-chiro-inositol, a phosphoglycan involved in insulin uptake (Luorno et al., 2002).

References available from the authors.

Contact Information:

Cheryl Allen, BASc

Dandle Crake, BASc

Heather Wilson, BASc

Andrea Buchholz, PhD, RD

(Faculty Advisor)

University of Guelph

Guelph,ON

abuchhol@uoguelph.ca

(519) 824-4120 (52347)

Copyright Dietitians of Canada Summer 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Hyperandrogenism
Home Contact Resources Exchange Links ebay